KELLY HUNT: Open Payments
NPI 1659656858 · MARSHALL, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,219 in 65 payments from 11 companies in 2025. Trend: 2023 $598 · 2024 $773 · 2025 $1,219
Food & beverage: $1,039Education: $180
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 11 | $241 |
| Regeneron Healthcare Solutions, Inc. | 9 | $235 |
| UCB, Inc. | 14 | $222 |
| GENZYME CORPORATION | 12 | $210 |
| Lilly USA, LLC | 5 | $99 |
| ABBVIE INC. | 4 | $75 |
| Arcutis Biotherapeutics, Inc. | 3 | $53 |
| PFIZER INC. | 2 | $33 |
| Organon LLC | 3 | $20 |
| Novartis Pharmaceuticals Corporation | 1 | $16 |
Products named: DUPIXENT, TREMFYA, Bimzelx, TALTZ, SKYRIZI, Zoryve, CIBINQO, RINVOQ.
Industry payments across TX — which companies pay providers there.
